Journal profile · Endocrinology & Metabolism
Prostaglandins Leukotrienes and Essential Fatty Acids
ISSN 0952-3278 · eISSN 1532-2823 · Churchill Livingstone · SCOTLAND · Monthly · Founded 1988
Prostaglandins Leukotrienes and Essential Fatty Acids: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.44; hybrid open access; APC about USD 3,790; median 96 days to acceptance (69 articles, last 24 months); community-reported acceptance: fairly easy; 37 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Prostaglandins Leukotrienes and Essential Fatty Acids is published by Churchill Livingstone and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Fatty Acid Research and Health, Eicosanoids and Hypertension Pharmacology and Inflammatory mediators and NSAID effects, together about 39.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The role of lipids, including essential fatty acids and their prostaglandin, leukotriene and other derivatives, is now evident in almost all areas of biomedical science. Cell membrane behaviour and cell signalling in all tissues are highly dependent on the lipid constituents of cells. Prostaglandins, Leukotrienes & Essential Fatty Acids aims to cover all aspects of the roles of lipids in cellular, organ and whole organism function, and places a particular emphasis on human studies. Papers concerning all medical specialties are published. Much of the material is particularly relevant to the development of novel treatments for disease.
From the journal's Aims & Scope
Research area (LetPub): Endocrinology & Metabolism
Editor-in-chief Richard P. BazinetPublisher website
Editorial board by country: none in mainland China; most named United States 8, Canada 7, Italy 6, Sweden 3, United Kingdom 2 (33 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Fatty Acid Research and HealthNursing20.8%
- Eicosanoids and Hypertension PharmacologyBiochemistry, Genetics and Molecular Biology9.7%
- Inflammatory mediators and NSAID effectsMedicine9.2%
- Peroxisome Proliferator-Activated ReceptorsBiochemistry, Genetics and Molecular Biology6.1%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance4.4%
- Human auditory perception and evaluationEngineering4%
- Nitric Oxide and Endothelin EffectsMedicine3.7%
- Cholesterol and Lipid MetabolismMedicine3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Cell Biology | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Cell Biology | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.44LetPub ·
- Impact factor (publisher)
- 2.4Publisher website ·
- CiteScore 2026-06
- 5.8LetPub ·
- CiteScore (publisher)
- 5.8Publisher website ·
- SJR 2026-06
- 0.83LetPub ·
- SNIP 2026-06
- 0.78LetPub ·
- h-index
- 96LetPub ·
- h-index
- 139OpenAlex ·
- i10-index
- 2,405OpenAlex ·
- 2-year mean citedness
- 2.36OpenAlex ·
- Self-citation rate
- 4.2%LetPub ·
- Share of gold OA articles
- 31.25%LetPub ·
Volume
- Articles per year
- 34LetPub ·
Articles by year OpenAlex count · 4,725 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 37 | 20 | 14 |
| 2025 | 37 | 18 | 80 |
| 2024 | 43 | 26 | 182 |
| 2023 | 46 | 24 | 313 |
| 2022 | 61 | 27 | 735 |
| 2021 | 77 | 30 | 920 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
96 daysMedian, submission to acceptance · P25–P75 69 days – 131 days
- Acceptance to online
- median 2 days (69 articles)
- Submission to online
- median 99 days
- Sample
- 69 articles with submission and acceptance dates (69 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 22 daysPublisher website ·
- First decision after review
- 86 daysPublisher website ·
- Submission to acceptance
- 97 daysPublisher website ·
- Acceptance to publication
- 3 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,790 / EUR 3,550 / GBP 3,030 / JPY 470,070 | — | — | |
| Publisher website | USD 3,950 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Abstract
- ≤ 250 words
- Reference style
- Numbered, in order of citation
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
All authors must have made substantial contributions to conception/design/data, drafting/revising, and final approval. Model summary
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Authors must follow Elsevier's Publishing Ethics Policy. Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process. Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed; does not count as prior publication. Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Churchill Livingstone
- Country or region
- SCOTLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1988
- ISSN
- 0952-3278
- Electronic ISSN
- 1532-2823
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Prostaglandins Leukotrienes and Essential Fatty Acids
What CAS zone is Prostaglandins Leukotrienes and Essential Fatty Acids in?
In the 2025 upgraded edition of the CAS Journal Ranking, Prostaglandins Leukotrienes and Essential Fatty Acids is in Zone 4 of Medicine, and in Zone 3 of the minor category Biochemistry & Molecular Biology / Cell Biology / Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Prostaglandins Leukotrienes and Essential Fatty Acids?
The latest impact factor listed by LetPub is 2.44; CiteScore 5.8, h-index 139.
How long does peer review take at Prostaglandins Leukotrienes and Essential Fatty Acids?
Based on the dates recorded on 69 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 96 days (interquartile range 69–131 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Prostaglandins Leukotrienes and Essential Fatty Acids?
According to the journal's author guidelines: Abstract: ≤ 250 words; Reference style: Numbered, in order of citation. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Prostaglandins Leukotrienes and Essential Fatty Acids based?
Of the 33 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (8), Canada (7) and Italy (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Prostaglandins Leukotrienes and Essential Fatty Acids?
According to LetPub and DOAJ records, Prostaglandins Leukotrienes and Essential Fatty Acids is indexed in SCIE and Scopus.
Is Prostaglandins Leukotrienes and Essential Fatty Acids open access, and what is the APC?
Prostaglandins Leukotrienes and Essential Fatty Acids is a hybrid journal. For open-access publication: APC about USD 3,790.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .